Ig/EBP (C/EBPγ) is a transdominant negative inhibitor of C/EBP family transcriptional activators
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Analysis of cDNA and genomic clones shows that the murine Ig/EBP (C/EBP gamma) gene encodes a small protein with a predicted molecular weight of 16.4 kDa which contains C/EBP family basic and leucine zipper domains but lacks the transcriptional activation domains present in C/EBP (C/EBP alpha) and NF-IL6 (C/EBP beta). In transfection assays Ig/EBP is neither an activator nor a repressor of transcription; however, Ig/EBP inhibits the transcriptional ability of NF-IL6 (C/EBP beta) and C/EBP (C/EBP alpha), acting as a transdominant negative regulator. Thus Ig/EBP resembles LIP, another negative regulator of the C/EBP family, in both structure and transcriptional activity. Of the three known C/EBP family inhibitors, Ig/EBP, LIP and CHOP-10, only Ig/EBP is ubiquitously expressed. Therefore, Ig/EBP may act as a general buffer for C/EBP activators in many cell types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CCAAT-Enhancer Binding Protein: A Component of a Differentiation Switch
Umek, R. M., Friedman, A. D., & McKnight, S. L. (1991) · Science · doi:10.1126/science.1987644 · Cited by 712
Birkenmeier, E. H., Gwynn, B., Howard, S., Jerry, J., Gordon, J. I., Landschulz, W. H., & McKnight, S. L. (1989) · Genes & Development · doi:10.1101/gad.3.8.1146 · Cited by 613
Johnson, P. F., Landschulz, W. H., Graves, B. J., & McKnight, S. L. (1987) · Genes & Development · doi:10.1101/gad.1.2.133 · Cited by 595
Descombes, P., Chojkier, M., Lichtsteiner, S., Falvey, E., & Schibler, U. (1990) · Genes & Development · doi:10.1101/gad.4.9.1541 · Cited by 575
Vinson, C. R., Hai, T., & Boyd, S. M. (1993) · Genes & Development · doi:10.1101/gad.7.6.1047 · Cited by 336
Kinoshita, S., Akira, S., & Kishimoto, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1473 · Cited by 327
Friedman, A. D., & McKnight, S. L. (1990) · Genes & Development · doi:10.1101/gad.4.8.1416 · Cited by 162
Cited by
CCAAT/enhancer-binding proteins: structure, function and regulation
RAMJI, D. P., & FOKA, P. (2002) · Biochemical Journal · doi:10.1042/bj20020508 · Cited by 1,400
Biological Role of the CCAAT/Enhancer-binding Protein Family of Transcription Factors
Lekstrom-Himes, J., & Xanthopoulos, K. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28545 · Cited by 801
Transcriptional regulation of granulocyte and monocyte development
Friedman, A. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205324 · Cited by 324
Tsukada, J., Yoshida, Y., Kominato, Y., & Auron, P. E. (2011) · Cytokine · doi:10.1016/j.cyto.2010.12.019 · Cited by 317
Robinson, G. W., Johnson, P. F., Hennighausen, L., & Sterneck, E. (1998) · Genes & Development · doi:10.1101/gad.12.12.1907 · Cited by 257
Akasaka, T., Balasas, T., Russell, L. J., Sugimoto, K.-J., Majid, A., Walewska, R., Karran, E. L., Brown, D. G., Cain, K., Harder, L., et al. (2007) · Blood · doi:10.1182/blood-2006-08-041012 · Cited by 215
Schrem, H., Klempnauer, J., & Borlak, J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.5 · Cited by 211
“Thus, C/EBP- resembles LIP, another aforementioned negative regulator of the C/EBP family, in both structure and transcriptional activity (Cooper et al., 1995).”
BackgroundYamanaka, R., Kim, G.-D., Radomska, H. S., Lekstrom-Himes, J., Smith, L. T., Antonson, P., Tenen, D. G., & Xanthopoulos, K. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6462 · Cited by 180
Zahnow, C. A. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001033 · Cited by 180
A Robust and Highly Efficient Immune Cell Reprogramming System
Bussmann, L. H., Schubert, A., Vu Manh, T. P., De Andres, L., Desbordes, S. C., Parra, M., Zimmermann, T., Rapino, F., Rodriguez-Ubreva, J., Ballestar, E., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.10.004 · Cited by 160
“C/EBPb and C/EBPd are known to have roles in myelomonocytic cell function and development (Friedman, 2007) whereas C/EBPg is a dominant-negative inhibitor of the other family members (Cooper et al., 1995).”
Chen, W., Yang, C.-C., Sheu, H.-M., Seltmann, H., & Zouboulis, C. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12411.x · Cited by 157
Regulation of senescence and the SASP by the transcription factor C/EBPβ
Salotti, J., & Johnson, P. F. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110752 · Cited by 103
Hu, H.-M., Baer, M., Williams, S. C., Johnson, P. F., & Schwartz, R. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2334 · Cited by 80
Synergistic Activation of the Germline ε Promoter Mediated by Stat6 and C/EBPβ
Mikita, T., Kurama, M., & Schindler, U. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1822 · Cited by 58
Williamson, E. A., Xu, H. N., Gombart, A. F., Verbeek, W., Chumakov, A. M., Friedman, A. D., & Koeffler, H. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.14796 · Cited by 50
LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer
Murray, C. W., Brady, J. J., Han, M., Cai, H., Tsai, M. K., Pierce, S. E., Cheng, R., Demeter, J., Feldser, D. M., Jackson, P. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28619-8 · Cited by 22
Metadata
- Authors
- Cooper, C., Henderson, A., Artandi, S., Avitahl, N., & Calame, K.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1995
- Volume
- 23
- Issue
- 21
- Pages
- 4371-4377
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2000213570
- Cited by
- 133
- References
- 7
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.